Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 44

Sort by

Sort Order Select

Journal Articles

Polygenic Risk Score and Risk of Chronic Lymphocytic Leukemia, Monoclonal B-Cell Lymphocytosis (MBL), and MBL Subtypes

Geffen Kleinstern, PhD, J. Brice Weinberg, MD, Sameer A. Parikh, MD, Esteban Braggio, PhD, Dennis P. Robinson, Aaron D. Norman, MPH, Kari G Rabe, Celine M. Vachon, PhD, Connie E. Lesnick, Timothy G. Call, MD, Danielle M. Brander, MD, Janet E. Olson, PhD, James R. Cerhan, MD PhD, Neil E. Kay, MD, Curtis A. Hanson, MD, Richard R. Furman, MD, Tait Shanafelt, MD, Susan L. Slager, PhD

Blood (2020) 136 (Supplement 1): 35–36.

https://doi.org/10.1182/blood-2020-136548

Published: 2020

Journal Articles

Exercise and Chronic Lymphocytic Leukemia (CLL) - Relationships Among Physical Activity, Fitness, & Inflammation, and Their Impacts on CLL Patients

Andrea Sitlinger, MD, Dana P Thompson, PhD, Michael A Deal, BS, Erwin Garcia, PhD, Tiffany Stewart, BS, Eross Guadalupe, BS, J. Brice Weinberg, MD, David A Bartlett, PhD, Danielle M. Brander, MD

Blood (2018) 132 (Supplement 1): 5540.

https://doi.org/10.1182/blood-2018-99-117736

Published: 2018

Journal Articles

PI3K-Delta Inhibitors Induce Primary Monocyte Cytotoxicity but Do Not Alter Monocyte Differentiation

Daphne Friedman, MD, Alicia Volkheimer, Eross Guadalupe, Dave Maryanski, BS, Hari P Miskin, MSc, J. Brice Weinberg, MD

Blood (2017) 130 (Supplement 1): 4284.

https://doi.org/10.1182/blood.V130.Suppl_1.4284.4284

Published: 2017

Journal Articles

Fingolimod Is Cytotoxic in Acute Myeloid Leukemia Independent of Additional Chemotherapeutic Agents

Carter Thomas Davis, MD, Arati V. Rao, MD, Eross Guadalupe, Dale J. Christensen, PhD, J. Brice Weinberg, MD

Blood (2016) 128 (22): 5126.

https://doi.org/10.1182/blood.V128.22.5126.5126

Published: 2016

Journal Articles

Surface CD5 Protein Risk Stratifies Chronic Lymphocytic Leukemia

Daphne R. Friedman, MD, Eross Guadeloupe, Alicia Volkheimer, J. Brice Weinberg, MD

Blood (2016) 128 (22): 3212.

https://doi.org/10.1182/blood.V128.22.3212.3212

Published: 2016

Journal Articles

Ruxolitinib Used to Treat Hypereosinophilic Syndrome

Seung Lee, bs, Coby Palmares, Niko Koutsoukos, J. Brice Weinberg, MD, Trisa Palmares, MD, Alice Song, MD, Harold Song, MD, Sheila Benedicto, bs, Michael Song, bs, Vu Phan, MD, Julia Song, MD

Blood (2016) 128 (22): 5500.

https://doi.org/10.1182/blood.V128.22.5500.5500

Published: 2016

Journal Articles

Final Clinical Results with Laboratory Correlates in the Phase I Trial of Lenalidomide Plus Plerixafor in Previously Treated Chronic Lymphocytic Leukemia (CLL)

Danielle M. Brander, MD, Sallie D. Allgood, MS, David A. Rizzieri, MD, Tiffany Stewart, BS, J. Brice Weinberg, MD, Mark C Lanasa, MD PhD

Blood (2014) 124 (21): 5658.

https://doi.org/10.1182/blood.V124.21.5658.5658

Published: 2014

Journal Articles

Double IGHV Gene Rearrangements in Chronic Lymphocytic Leukemia

Benjamin M Heyman, MD, Alicia D. Volkheimer, MS, J. Brice Weinberg, MD, Mark Lanasa, MD PhD

Blood (2014) 124 (21): 5631.

https://doi.org/10.1182/blood.V124.21.5631.5631

Published: 2014

Journal Articles

Acute and Chronic Lymphocytic Leukemia Induces Exhaustion and Suppresses Metabolic Reprogramming in T Cell Activation

Peter J. Siska, MD, J. Brice Weinberg, MD, Arati V. Rao, MD, James R. Bain, PhD, Michael J. Muehlbauer, PhD, Tingyu Liu, Jeffrey Rathmell, PhD

Blood (2014) 124 (21): 4121.

https://doi.org/10.1182/blood.V124.21.4121.4121

Published: 2014

Journal Articles

Absolute Monocyte Count and Serum CD14 As Prognostic Markers In Chronic Lymphocytic Leukemia

Daphne R. Friedman, MD, Kathleen K. Harnden, MD,, Youwei Chen, MD, Alicia D. Volkheimer, MS, J. Brice Weinberg, MD

Blood (2013) 122 (21): 5297.

https://doi.org/10.1182/blood.V122.21.5297.5297

Published: 2013

Journal Articles

Laboratory Correlates and a Phase I Clinical Trial Of Lenalidomide In Combination With Plerixafor In Patients With Previously Treated Chronic Lymphocytic Leukemia

Danielle M. Brander, MD, Sallie D. Allgood, MS, Tiffany M. Simms, BS, J. Brice Weinberg, MD, Mark Lanasa, MD, PhD

Blood (2013) 122 (21): 5301.

https://doi.org/10.1182/blood.V122.21.5301.5301

Published: 2013

Journal Articles

Molecular and Clinical Associations Between Vitamin D and Chronic Lymphocytic Leukemia

Nina Beri, MD, Daphne R. Friedman, MD, Tiffany M. Simms, BS, Maragatha Kuchibhatla, PhD, J. Brice Weinberg, MD, Mark C. Lanasa, MD, PhD

Blood (2013) 122 (21): 5282.

https://doi.org/10.1182/blood.V122.21.5282.5282

Published: 2013

Journal Articles

The Relationship Between Socioeconomic Status and Clinical Outcomes in African Americans with Chronic Lymphocytic Leukemia

Catherine C Coombs, MD, J. Brice Weinberg, MD, Mark C. Lanasa, MD, PhD

Blood (2012) 120 (21): 3912.

https://doi.org/10.1182/blood.V120.21.3912.3912

Published: 2012

Journal Articles

The Metabolic Signature of CLL: Enhanced Glucose Metabolism in A Subset of High-Risk CLL Patients

Tingyu Liu, BS, J. Brice Weinberg, MD, Evan D. Davis, Alicia D. Volkheimer, MS, Jeffrey Rathmell, PhD

Blood (2012) 120 (21): 1785.

https://doi.org/10.1182/blood.V120.21.1785.1785

Published: 2012

Journal Articles

CD38 Variation in Chronic Lymphocytic Leukemia

Ryan D. Nipp, M.D., J. Brice Weinberg, MD, Alicia D. Volkheimer, M.S., Evan D. Davis, Youwei Chen, MD, Daphne R. Friedman, M.D.

Blood (2012) 120 (21): 4576.

https://doi.org/10.1182/blood.V120.21.4576.4576

Published: 2012

Journal Articles

Comparison of the PI3K-δ Inhibitors TGR1202 and GS-1101 in Inducing Cytotoxicity and Inhibiting Phosphorylation of Akt in CLL Cells in Vitro

Daphne R. Friedman, M.D., Mark C. Lanasa, MD, PhD, Danielle M. Brander, MD, Sallie D. Allgood, MS, Evan D. Davis, BS, Hari Miskin, Srikant Viswanadha, Swaroop Vakkalanka, J. Brice Weinberg, MD

Blood (2012) 120 (21): 3914.

https://doi.org/10.1182/blood.V120.21.3914.3914

Published: 2012

Journal Articles

Prevalence of MBL Increases Over Time In Relatives of CLL Families,

Susan L Slager, PhD, Mark C Lanasa, MD, PhD, Sallie D. Allgood, MS, Sara J Achenbach, Aaron Norman, MS, Celine M Vachon, PhD, Lynn Goldin, PhD, Jose F. Leis, MD, PhD, Neil Kay, MD, J. Brice Weinberg, MD, Kari Rabe, MS, Timothy G. Call, MD, James R Cerhan, MD, PhD, Tait D. Shanafelt, MD, Neil E Caporaso, MD, Gerald E Marti, MD, PhD, Curtis A. Hanson, MD

Blood (2011) 118 (21): 3881.

https://doi.org/10.1182/blood.V118.21.3881.3881

Published: 2011

Journal Articles

The Role of Surface Immunoglobulin Isotype in Chronic Lymphocytic Leukemia Disease Biology and Clinical Outcome

Danielle M. Brander, MD, Sallie D. Allgood, MS, Karen M. Bond, BS, J. Brice Weinberg, MD, Mark C Lanasa, MD, PhD

Blood (2011) 118 (21): 2850.

https://doi.org/10.1182/blood.V118.21.2850.2850

Published: 2011

Journal Articles

Chronic Lymphocytic Leukemia Shares a Common Cellular Origin with Regulatory B10 Cells

J. Brice Weinberg, MD, David J. DiLillo, PhD, Yohei Iwata, PhD, Takashi Matushita, PhD, Karen M. Matta, BS, Guglielmo M. Venturi, PhD, Giandomenico Russo, MD, PhD, Youwei Chen, MD, Jon P. Gockerman, MD, Joseph O. Moore, MD, Louis F. Diehl, MD, Alicia D. Volkheimer, MS, Daphne R. Friedman, M.D., Mark C Lanasa, MD, PhD, Russell P. Hall, MD, Thomas J. Tedder, PhD

Blood (2011) 118 (21): 286.

https://doi.org/10.1182/blood.V118.21.286.286

Published: 2011

Journal Articles

Race As a Determinant of Disease Biology and Outcomes in Chronic Lymphocytic Leukemia

Catherine C Coombs, MD, Laura Z. Rassenti, Ph.D., Susan L Slager, PhD, Sara Strom, PhD, J. Brice Weinberg, MD, Thomas J Kipps, MD, PhD, Mark C Lanasa, MD, PhD

Blood (2011) 118 (21): 1785.

https://doi.org/10.1182/blood.V118.21.1785.1785

Published: 2011

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Polygenic Risk Score and Risk of Chronic Lymphocytic Leukemia, Monoclonal B-Cell Lymphocytosis (MBL), and MBL Subtypes

Exercise and Chronic Lymphocytic Leukemia (CLL) - Relationships Among Physical Activity, Fitness, & Inflammation, and Their Impacts on CLL Patients

PI3K-Delta Inhibitors Induce Primary Monocyte Cytotoxicity but Do Not Alter Monocyte Differentiation

Fingolimod Is Cytotoxic in Acute Myeloid Leukemia Independent of Additional Chemotherapeutic Agents

Surface CD5 Protein Risk Stratifies Chronic Lymphocytic Leukemia

Ruxolitinib Used to Treat Hypereosinophilic Syndrome

Final Clinical Results with Laboratory Correlates in the Phase I Trial of Lenalidomide Plus Plerixafor in Previously Treated Chronic Lymphocytic Leukemia (CLL)

Double IGHV Gene Rearrangements in Chronic Lymphocytic Leukemia

Acute and Chronic Lymphocytic Leukemia Induces Exhaustion and Suppresses Metabolic Reprogramming in T Cell Activation

Absolute Monocyte Count and Serum CD14 As Prognostic Markers In Chronic Lymphocytic Leukemia

Laboratory Correlates and a Phase I Clinical Trial Of Lenalidomide In Combination With Plerixafor In Patients With Previously Treated Chronic Lymphocytic Leukemia

Molecular and Clinical Associations Between Vitamin D and Chronic Lymphocytic Leukemia

The Relationship Between Socioeconomic Status and Clinical Outcomes in African Americans with Chronic Lymphocytic Leukemia

The Metabolic Signature of CLL: Enhanced Glucose Metabolism in A Subset of High-Risk CLL Patients

CD38 Variation in Chronic Lymphocytic Leukemia

Comparison of the PI3K-δ Inhibitors TGR1202 and GS-1101 in Inducing Cytotoxicity and Inhibiting Phosphorylation of Akt in CLL Cells in Vitro

Prevalence of MBL Increases Over Time In Relatives of CLL Families,

The Role of Surface Immunoglobulin Isotype in Chronic Lymphocytic Leukemia Disease Biology and Clinical Outcome

Chronic Lymphocytic Leukemia Shares a Common Cellular Origin with Regulatory B10 Cells

Race As a Determinant of Disease Biology and Outcomes in Chronic Lymphocytic Leukemia

Email alerts

ASH Publications

American Society of Hematology